Live News EQUITY M impact Jun 26, 2026, 12:00 PM UTC

ENSC Enrolls Patient

Ensysce Biosciences enrolls first patient in final phase of PF614-MPAR-102 clinical study

SQUAWKNEWS Updated Jun 26, 2026, 12:00 PM UTC

ENSC - Ensysce Biosciences Enrolls First Patient in Final Phase of PF614-MPAR-102 Clinical Study